/STEK
STEK Stock - Stemtech Corporation
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+16.67%
+$0.00 (+16.67%) • Dec 19
41
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.31
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for STEK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.22
52W High$0.06
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.05M | $4.92M | $4.56M | $4.32M | $4.38M |
| Gross Profit | $3.73M | $3.92M | $3.40M | $3.30M | $3.67M |
| Gross Margin | 73.8% | 79.6% | 74.5% | 76.3% | 83.7% |
| Operating Income | $-2,386,427 | $-4,224,546 | $-5,023,380 | $-3,210,271 | $-1,431,799 |
| Net Income | $-3,769,566 | $-5,430,245 | $-8,632,828 | $-15,283,655 | $-1,727,658 |
| Net Margin | -74.6% | -110.3% | -189.3% | -353.7% | -39.4% |
| EPS | $-0.03 | $-0.07 | $-0.19 | $-0.41 | $-3.20 |
Company Overview
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. The company is based in Miramar, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
STEKBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q3 2023
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Sep 30, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.04 | — | — |
Q4 2022 | Dec 31, 2022 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about STEK
What is STEK's current stock price?
Stemtech Corporation (STEK) is currently trading at $0.00 per share. The stock has moved +16.67% today.
What is the analyst price target for STEK?
No analyst price targets are currently available for this stock.
What sector is Stemtech Corporation in?
Stemtech Corporation operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is STEK's market cap?
Stemtech Corporation has a market capitalization of $0.00 billion, making it a small-cap company.
Does STEK pay dividends?
No, Stemtech Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorDYNT
Dynatronics Corporation
$0.04
Mkt Cap: $0.0B
ERBB
American Green, Inc.
$0.00
Mkt Cap: $0.0B
GEATF
Radiko Holdings Corp.
$0.00
Mkt Cap: $0.0B
GRCU
Green Cures & Botanical Distribution Inc.
$0.00
Mkt Cap: $0.0B
GRPS
Gold River Productions, Inc.
$0.00
Mkt Cap: $0.0B
NRXCF
NeutriSci International Inc.
$0.00
Mkt Cap: $0.0B
STSN
Stemsation International, Inc.
$0.00
Mkt Cap: $0.0B
TRLFF
Maven Brands Inc.
$0.00
Mkt Cap: $0.0B
VRTHF
Indigenous Bloom Hemp Corp.
$0.00
Mkt Cap: $0.0B
XBRAF
Xebra Brands Ltd.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to STEK for comparison